ATE169504T1 - Therapeutische mittel - Google Patents

Therapeutische mittel

Info

Publication number
ATE169504T1
ATE169504T1 AT92922888T AT92922888T ATE169504T1 AT E169504 T1 ATE169504 T1 AT E169504T1 AT 92922888 T AT92922888 T AT 92922888T AT 92922888 T AT92922888 T AT 92922888T AT E169504 T1 ATE169504 T1 AT E169504T1
Authority
AT
Austria
Prior art keywords
compound
protein
specific
direct
antisense oligonucleotide
Prior art date
Application number
AT92922888T
Other languages
English (en)
Inventor
Agamemnon Antoniou Epenetos
Original Assignee
Imp Cancer Res Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imp Cancer Res Tech filed Critical Imp Cancer Res Tech
Application granted granted Critical
Publication of ATE169504T1 publication Critical patent/ATE169504T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
AT92922888T 1991-11-12 1992-11-10 Therapeutische mittel ATE169504T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919123947A GB9123947D0 (en) 1991-11-12 1991-11-12 Therapeutic compounds

Publications (1)

Publication Number Publication Date
ATE169504T1 true ATE169504T1 (de) 1998-08-15

Family

ID=10704443

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92922888T ATE169504T1 (de) 1991-11-12 1992-11-10 Therapeutische mittel

Country Status (8)

Country Link
EP (1) EP0613379B1 (de)
JP (1) JPH07504885A (de)
AT (1) ATE169504T1 (de)
DE (1) DE69226646T2 (de)
DK (1) DK0613379T3 (de)
ES (1) ES2125275T3 (de)
GB (2) GB9123947D0 (de)
WO (1) WO1993009813A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19644302A1 (de) * 1995-11-28 1997-06-05 Boehringer Mannheim Gmbh Verfahren zum Nachweis von Telomerase-Aktivität
US6776986B1 (en) 1996-06-06 2004-08-17 Novartis Ag Inhibition of HIV-1 replication by antisense RNA expression
US5821354A (en) * 1996-11-26 1998-10-13 Angiogene Inc. Radiolabeled DNA oligonucleotide and method of preparation
US6228642B1 (en) 1998-10-05 2001-05-08 Isis Pharmaceuticals, Inc. Antisense oligonucleotide modulation of tumor necrosis factor-(α) (TNF-α) expression
US6080580A (en) * 1998-10-05 2000-06-27 Isis Pharmaceuticals Inc. Antisense oligonucleotide modulation of tumor necrosis factor-α (TNF-α) expression
DK2284266T3 (da) * 2002-11-14 2014-01-13 Thermo Fisher Scient Biosciences Inc sIRNA-MOLEKYLE MOD TP53
MA45328A (fr) * 2016-04-01 2019-02-06 Avidity Biosciences Llc Compositions acide nucléique-polypeptide et utilisations de celles-ci

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837003A (en) * 1984-09-13 1989-06-06 Mallinckrodt, Inc. Radiolabeled antibody fragments
US5109124A (en) * 1988-06-01 1992-04-28 Biogen, Inc. Nucleic acid probe linked to a label having a terminal cysteine
CA1339775C (en) * 1988-06-10 1998-03-24 Shuzo Matsushita Antibody 0.5b to hiv-i gp 120 modified with toxic substance
WO1990010448A2 (en) * 1989-03-07 1990-09-20 Genentech, Inc. Covalent conjugates of lipid and oligonucleotide
WO1991004753A1 (en) * 1989-10-02 1991-04-18 Cetus Corporation Conjugates of antisense oligonucleotides and therapeutic uses thereof
US5169934A (en) * 1990-05-14 1992-12-08 Anergen, Inc. Intracellularly cleavable compounds
IL99069A (en) * 1990-08-09 1998-08-16 Genta Inc Methyphosphonate oligonucleotides associated with psoralen
IE914220A1 (en) * 1990-12-10 1992-06-17 Akzo Nv Labelled, modified oligonucleotides

Also Published As

Publication number Publication date
WO1993009813A1 (en) 1993-05-27
ES2125275T3 (es) 1999-03-01
GB2275928B (en) 1995-09-06
GB2275928A (en) 1994-09-14
GB9409156D0 (en) 1994-07-13
EP0613379B1 (de) 1998-08-12
GB9123947D0 (en) 1992-01-02
DK0613379T3 (da) 1999-05-10
JPH07504885A (ja) 1995-06-01
EP0613379A1 (de) 1994-09-07
DE69226646D1 (de) 1998-09-17
DE69226646T2 (de) 1999-04-08

Similar Documents

Publication Publication Date Title
Gaddis et al. Comprehensive investigation of the molecular defect in vif-deficient human immunodeficiency virus type 1 virions
DE69534568D1 (de) Säugetier-telomerase
KR960701219A (ko) 사람의 면역결핍 바이러스 타입1의 검출(Detection of Human Immunodeficiency Virus Type 1)
CO4750842A1 (es) Pox virus recombinantes de mapache y vacuna eficaz contra la infeccion del virus de inmunodeficiencia felina .
Ensoli et al. AIDS-associated Kaposi's sarcoma: a molecular model for its pathogenesis
DE69226646D1 (de) Therapeutische Mittel
DE69732029D1 (de) Dna enthaltende impfstoffen
DE60044754D1 (de) Trans-lentivirales Vektor System
NO980212D0 (no) Primere påvisning av HIV-1
DK637988D0 (da) Rekombinante polypeptider
FR2651505B1 (fr) Fragments d'acides nucleiques derives d'un genome de mycobacterie appropriee, leurs applications dans le diagnostic des infections a mycobacteries et plasmides contenant lesdits fragments.
DE69626681D1 (de) Konditionell-replizierende virale vektoren und ihre verwendung.
FR2600079B1 (fr) Vecteur viral et adn recombinant codant pour la proteine f du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la proteine, proteine obtenue, vaccin et anticorps obtenus
ATE346087T1 (de) Hepatitis e-virus aus dem schwein und dessen verwendungen
WO2001009173A3 (fr) Utilisation des acides quinique, shikimique et de leurs derives pour la preparation de ligands du recepteur du mannose
ES2092568T3 (es) Identificacion de nuevos farmacos y reactivos.
FR2646606B1 (fr) Retrovirus hautement cytopathogenique hiv-ndk. fragment d'adn de ce retrovirus, procede de preparation d'une proteine et/ou enzyme de ce virus et leurs utilisations
Smart Zinc fingers--the next antiviral target?
Marx AIDS virus genomes
GB2300259B (en) Diagnostic and therapeutic system
FR2644176B1 (fr) Retrovirus viscpz infectant naturellement le chimpanze, fragments d'adn de ce retrovirus, procede de preparation d'une proteine et/ou d'une enzyme de ce virus et leurs utilisations
Iordan et al. Effect of vitamin B sub (12) on DNA synthesis of Propionibacterium
WO1998035684A3 (en) Methods for detection of kaposi's sarcoma-associated herpesvirus-like virus
Hovanessian et al. Techniques in HIV research: Edited by A. Aldovini and BD Walker. New York: Stockton Press.(1990). 285 pp. $49.95
KR950000879A (ko) 신규한 인간 면역결핍 바이러스-2(hiv-2)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee